Stockreport

Third Harmonic Bio Announces Fourth Quarter and Full Year 2023 Financial Results

Third Harmonic Bio, Inc.  (THRD) 
PDF U.S. IND filed for THB335 with anticipated clinical trial start during 2Q’24 Strong financial position with cash and cash equivalents totaling $269.1 million as of De [Read more]